•
Jun 30, 2021

OptimizeRx Q2 2021 Earnings Report

Total Revenue
$13.6M
Previous year: $8.78M
+55.1%
EPS
$0.1
Previous year: $0.02
+400.0%
Gross Margin
59%
Gross Profit
$8.04M
Previous year: $5.14M
+56.4%
Cash and Equivalents
$83.9M
Previous year: $14.1M
+494.6%
Free Cash Flow
$166K
Previous year: $119K
+40.1%
Total Assets
$132M
Previous year: $56.1M
+134.8%

OptimizeRx

OptimizeRx